Results 71 to 80 of about 57,330 (350)

Fenofibrate-Induced Lichenoid Drug Eruption: A Rare Culprit

open access: yesCase Reports in Dermatology, 2017
A lichenoid drug eruption is a rare side effect which can occur following the administration of several different medications. Here we describe a unique case of fenofibrate as the causative agent of a lichenoid drug eruption.
Fayeza Mohammed   +4 more
doaj   +1 more source

A mechanistic study on the phototoxicity of atorvastatin: singlet oxygen generation by a phenanthrene-like photoproduct [PDF]

open access: yes, 2009
Atorvastatin calcium (ATV) is one of the most frequently prescribed drugs worldwide. Among the adverse effects observed for this lipid-lowering agent, clinical cases of cutaneous adverse reactions have been reported and associated with photosensitivity ...
IESCE, MARIA ROSARIA   +4 more
core   +1 more source

BRAF inhibitor and hairy cell leukemia-related transient acantholytic dermatosis [PDF]

open access: yes, 2020
Grover disease (GD) is an acquired, nonfamilial, nonimmune mediated, transient or persistent acantholytic dermatosis. Herein, we present a 72-year-old man who had clinical and histopathologic findings of GD following two weeks of treatment with ...
Durkin, John R   +3 more
core  

PRIDE Complex (Papulopustules and/or Paronychia, Regulatory Abnormalities of Hair Growth, Itching, Dryness Due to EGFR Inhibitors)

open access: yes
JEADV Clinical Practice, EarlyView.
Sweta Subhadarshani   +3 more
wiley   +1 more source

Erythema multiforme-like eruption from a slimming drug preparation cutaneous adverse drug reaction

open access: yesIndian Dermatology Online Journal, 2011
We report a case of a 34-year-old woman presenting with an erythema multiforme (EM)-like eruption. Lesions developed after a 12-day treatment with a slimming drug preparation (food integrator with thermogenic activity) and a herbal remedy (pilosella ...
Linda Tognetti   +2 more
doaj   +1 more source

Clinical Features in the Diagnosis of Drug Reaction With Eosinophilia and Systemic Symptoms: A Retrospective Cohort Study

open access: yes
JEADV Clinical Practice, EarlyView.
Allison Holt   +9 more
wiley   +1 more source

Prospective Evaluation of a Fractional 675‐nm Nonablative Laser for Atrophic Acne Scars in Fitzpatrick Skin Types III–IV

open access: yesLasers in Surgery and Medicine, EarlyView.
ABSTRACT Background Energy‐based treatments for atrophic acne scars (AAS) in darker skin phototypes must balance efficacy with pigmentary safety. While the nonablative 675‐nm laser has shown promise with minimal risk of adverse effects, prospective data in Asian populations remain limited.
Pinthisa Nisagornsen   +6 more
wiley   +1 more source

Eosinophilic dermatosis of hematologic malignancy: a case report [PDF]

open access: yes, 2020
Eosinophilic dermatosis of hematologic malignancy (EDHM) is a dermatosis characterized by tissue eosinophilia that has been previously reported as insect bite-like reaction.
Almeida, FT   +4 more
core  

Fixed drug eruption to cetirizine with positive lesional patch tests to the three piperazine derivatives [PDF]

open access: yes, 2007
BACKGROUND: The H1-antihistamine cetirizine, a piperazine derivative widely used in daily practice, is rarely the cause of cutaneous drug reaction.
Cravo, M   +2 more
core   +1 more source

Morphological and Computational Analysis of Additively Manufacturable Polyimide Precursors: Implications for Rationally Designing New Polyimide Structures

open access: yesMacromolecular Materials and Engineering, EarlyView.
Multiscale experiments and DFT calculations establish how polyimide precursor choice governs additively manufactured morphology. PMDA/ODA and PMDA/DDS printed via a polysalt vat photopolymerization route are compared by SEM, SAXS/WAXS, and TGA. PDMA/DDS displays reduced π‐stacking and lower thermal stability compared to PMDA/ODA.
Erin C. Jackson   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy